This study will test whether a single dose of Lamotrigine (300mg) exerts significant effects on emotional processing, cognitive ability and neural activity in healthy volunteers compared to placebo.
Glutamate has been implicated in the aetiology of mood disorders and there is current interest in developing novel agents targeting this system. However, the role of glutamate in human emotional function is relatively unknown. Lamotrigine's pharmacological profile involves a blockade of voltage-gated sodium channels, leading to an inhibition in the release of glutamate and resulting in a general inhibitory effect on cortical neuronal function. The current study plans to investigate the effects of modifying glutamate on emotional processing, cognitive function and neural activity. For this, 36 healthy volunteers will be recruited to the study and randomised to receive a single dose of lamotrigine (300 mg) or placebo. Two hours after drug administration, the effects of emotional processing via the use of cognitive tasks will be assessed using fMRI. This will be followed by an emotional test battery that will measure aspects of cognitive function as well.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Enrollment
36
Active Drug Capsule
Placebo Capsule
University of Oxford
Oxford, Oxfordshire, United Kingdom
Neural function
fMRI resting state analysis
Time frame: Data reporting and analysis to be completed within 1 year following study completion.
Neural function
fMRI task analysis
Time frame: Data reporting and analysis to be completed within 1 year following study completion.
Neural function
fMRI checkerboard analysis
Time frame: Data reporting and analysis to be completed within 1 year following study completion.
Emotional Processing and Cognitive Function
Analysis of recognition of emotion in faces (an Emotional Test Battery component)
Time frame: Data reporting and analysis to be completed within 6 months following study completion.
Emotional Processing and Cognitive Function
Speed of negative self-descriptor processing (an Emotional Test Battery component)
Time frame: Data reporting and analysis to be completed within 6 months following study completion.
Emotional Processing and Cognitive Function
Emotional memory analysis (an Emotional Test Battery component)
Time frame: Data reporting and analysis to be completed within 6 months following study completion.
Emotional Processing and Cognitive Function
Beck Depression inventory (BDI) questionnaire analysis
Time frame: Data reporting and analysis to be completed within 6 months following study completion.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Emotional Processing and Cognitive Function
Positive and negative affect schedule (PANAS) questionnaire analysis
Time frame: Data reporting and analysis to be completed within 6 months following study completion.
Emotional Processing and Cognitive Function
Stait-trait anxiety inventory (STAI) questionnaire analysis
Time frame: Data reporting and analysis to be completed within 6 months following study completion.